Home
News
All News
Patients and society set to benefit from innovation
It is exciting to see the advances in science, and the diversity in innovation coming from pharmaceutical companies to address these health challenges
Despite a decade of gradual growth, R&D spending in Europe outpaced by the US
New research published today by EFPIA provides in-depth analysis of the economic footprint
#WeWontRest
Illness never sleeps so medical innovation can't rest either. Breakthroughs in pharmaceuticals which save lives only come about because of the passion and commitment of those who have dedicated their lives to discovering and developing new medicines for patients.
Take a look why #WeWon'tRest and how we fight to make the world a better place for everyone.
Medication Prices
Prices of prescription innovative medicines in Slovenia are subject of strict regulation. Pharmaceutical companies actively co-operate with relevant institutions in forming the prices of medication and strive to make medicine accessible.
Check out how the procedures of medication price forming work in Slovenia.
Value of Innovation
Healthcare innovations have an important influence on society and individuals. Innovative medicines improve the quality of life and prolong life expectancy. By developing these medicines pharmaceutical industry contributes to society's prosperity and to economic growth.
Discover why personal and social benefits of innovative medication far surpass their costs.
Europe's Choice
Europe has the potential to be a leader in the research, development and production of new medicines. Geopolitical shifts are reshaping the global life science landscape. However, by building on its strengths and taking decisive policy action, Europe can be competitive in the global race for pharmaceutical investment.
We represent innovative pharmaceutical industry in Slovenia and work as a non-governmental, non-profit, non-political and independent economic interest group. We connect 22 pharmaceutical companies which share a common goal: #WeWontRest in developing innovative medicines which hold the key to managing diseases and to improving the lives of patients.
The Patient as an Equal Partner: Health as an Investment in the Future
Patients and society set to benefit from innovation
It is exciting to see the advances in science, and the diversity in innovation coming from pharmaceutical companies to address these health challenges
Despite a decade of gradual growth, R&D spending in Europe outpaced by the US
New research published today by EFPIA provides in-depth analysis of the economic footprint